SQ HDM SLIT-tablet (ALK) in treatment of asthma - Post hoc results from a randomised trial

In this subgroup, including only patients with partly controlled asthma, the benefit of 1 year of treatment with SQ HDM SLIT-tablet was significantly higher than for the less severe full population, both in terms of increased asthma control and improved quality of life.